Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT03427151
200 mcg of IPP-201101 (FORIGERIMOD) will be administered subcutaneously every 4 weeks for 24 weeks.
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1JRB6UKG4Q
Created by
admin on Sat Dec 16 03:58:14 GMT 2023 , Edited by admin on Sat Dec 16 03:58:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103866
Created by
admin on Sat Dec 16 03:58:14 GMT 2023 , Edited by admin on Sat Dec 16 03:58:14 GMT 2023
|
PRIMARY | |||
|
XX-41
Created by
admin on Sat Dec 16 03:58:14 GMT 2023 , Edited by admin on Sat Dec 16 03:58:14 GMT 2023
|
PRIMARY | |||
|
9405
Created by
admin on Sat Dec 16 03:58:14 GMT 2023 , Edited by admin on Sat Dec 16 03:58:14 GMT 2023
|
PRIMARY | |||
|
C166505
Created by
admin on Sat Dec 16 03:58:14 GMT 2023 , Edited by admin on Sat Dec 16 03:58:14 GMT 2023
|
PRIMARY | |||
|
497156-60-2
Created by
admin on Sat Dec 16 03:58:14 GMT 2023 , Edited by admin on Sat Dec 16 03:58:14 GMT 2023
|
PRIMARY | |||
|
DB12490
Created by
admin on Sat Dec 16 03:58:14 GMT 2023 , Edited by admin on Sat Dec 16 03:58:14 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)